Unamuno P, Fernández-López E, Santos C
Department of Dermatology, Hospital Clínico Universitario, Salamanca, Spain.
Clin Exp Dermatol. 1992 Jul;17(4):273-4. doi: 10.1111/j.1365-2230.1992.tb02166.x.
Chromonychia induced by antineoplastic agents has been known for several years. The most frequent of these is melanonychia, either diffuse or in tranverse or longitudinal bands, that may co-exist with diffuse pigmentation of the skin. Although any cytostatic agent may be involved in melanonychia, this condition appears most commonly after treatment with adriamycin and cyclophosphamide or in polychemotherapy. Leukonychia, either true or apparent, seems to be less frequent and is the reason for our reporting two patients with this colour change.
抗肿瘤药物引起的甲变色已经被知晓数年。其中最常见的是甲黑素沉着,可为弥漫性、横向或纵向条纹状,可能与皮肤弥漫性色素沉着同时存在。尽管任何细胞毒性药物都可能导致甲黑素沉着,但这种情况最常出现在使用阿霉素和环磷酰胺治疗后或多药化疗过程中。真性或假性白甲似乎较少见,这也是我们报告两名出现这种颜色改变患者的原因。